A new manufacturing process is on track to make developing HIV-prevention medication more affordable and potentially decrease ...
A research team led by professor Olivia Merkel, Chair of Drug Delivery at LMU and co-spokesperson of the Cluster for Nucleic ...
Correcting misinformation after it has gone viral is a common way of informing the public that what they’ve encountered may ...
C&EN networking event in New York City. Please join us if you’re in town! Here’s a link to the invitation. Questions? Comments? Tips? Let us know. Email Michael McCoy, C&EN’s executive editor for ...
In two experiments, researchers have found that introducing people to "mental models" about how mRNA vaccination works and ...
Announces three-year business strategy and commercial growth drivers, targeting up to 10% revenue growth in 2026 Expects to ...
We spoke to the facility’s director about the state of CGTs and how the industry can rebuild confidence in advanced ...
TipRanks on MSN
Moderna provides update on global production network
The company said, “Since 2022, Moderna (MRNA) has streamlined its production sites into a global manufacturing network ready for new launches and ...
Moderna said on Wednesday it would now operate full end-to-end manufacturing for its mRNA medicines in the U.S., marking a major step in strengthening the company's domestic production network.
AGC Biologics is partnering with Repair Biotechnologies to develop and manufacture a novel mRNA therapy to rapidly stabilize ...
Pharmaceutical Technology on MSN
New protein manufacturing technologies likely to play key role in “five to ten years”
Eleva’s CEO says CHO cell line alternatives could become common as large molecule drugs become complex and harder to produce ...
New capabilities strengthen U.S. production, completing Moderna's domestic end-to-end mRNA manufacturing network ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback